Global Respiratory Disease Vaccine Market Report 2022: Increasing R&D Expenditure by Leading Companies Presents Opportunities - ResearchAndMarkets.com
The "Global Respiratory Disease Vaccine Market (2022-2027) by Infection, Type, Age Group, and Geography, Competitive Analysis and the Impact of COVID-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering
DUBLIN--(BUSINESS WIRE)--Nov 4, 2022--
The "Global Respiratory Disease Vaccine Market (2022-2027) by Infection, Type, Age Group, and Geography, Competitive Analysis and the Impact of COVID-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Respiratory Disease Vaccine Market is estimated to be USD 22.16 Bn in 2022 and is expected to reach USD 29.71 Bn by 2027, growing at a CAGR of 6.04%.
Market Segmentations
The Global Respiratory Disease Vaccine Market is segmented based on Infection, Type, Age Group, and Geography.
Countries Studied
Why buy this report?
Market Dynamics
Drivers
Restraints
Opportunities
Challenges
Report Highlights:
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global Respiratory Disease Vaccine Market, By Infection
7 Global Respiratory Disease Vaccine Market, By Type
8 Global Respiratory Disease Vaccine Market, By Age Group
9 Americas' Respiratory Disease Vaccine Market
10 Europe's Respiratory Disease Vaccine Market
11 Middle East and Africa's Respiratory Disease Vaccine Market
12 APAC's Respiratory Disease Vaccine Market
13 Competitive Landscape
14 Company Profiles
15 Appendix
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/noh0xx
View source version on businesswire.com:https://www.businesswire.com/news/home/20221104005527/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES OTHER HEALTH COVID-19 PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/04/2022 01:08 PM/DISC: 11/04/2022 01:08 PM
http://www.businesswire.com/news/home/20221104005527/en